Trial Profile
A Phase III Randomized, Double-Blind, Dexamethasone-Sparing Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Placebo for Control of Symptoms Associated With Peritumoral Brain Oedema in Patients With Malignant Brain Tumour Who Require Chronic Administration of High-Dose Dexamethasone
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Oct 2014
Price :
$35
*
At a glance
- Drugs Corticorelin (Primary)
- Indications Brain oedema
- Focus Registrational; Therapeutic Use
- Sponsors Celtic Pharma
- 10 Apr 2014 New trial record
- 10 Apr 2014 New trial record
- 06 Mar 2008